opioid use disorder
The round brings the company's total raise to $83 million.
The program launched in Florida in early March and will expand to other states in coming months.
This new infusion of cash brings the company's total raised to $68 million.
Peloton's M&A flurry, fertility wearables for COVID-19 detection and more digital health news briefs
Also: Boston Medical Center releases free app for clinicians treating OUD; ClearUP's OTC sinus relief device wins expanded indication.
Flare Capital's Alexandra Mullin and Ian Chiang outline COVID-19's impact on the worsening opioid crisis and how the digital opioid use disorder space is likely to develop over the coming years.
The study, backed by the digital therapeutics company, measured the change in clinical encounter frequency among opioid use disorder patients who were also prescribed buprenorphine.
The device applies electrical impulses to the cranial nerves around the ear, which can reduce neuron activity and opioid withdrawal symptoms.
An in-depth look at the market forces shaping the development and adoption (or lack thereof) of behavioral health technology.